| 000 | 01598 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512004251.0 | ||
| 264 | 0 | _c19890201 | |
| 008 | 198902s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRamos, O F | |
| 245 | 0 | 0 |
_aLymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cJan 1989 |
||
| 300 |
_a217-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntigens, Differentiation, B-Lymphocyte _xphysiology |
| 650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aComplement Activation _xdrug effects |
| 650 | 0 | 4 |
_aComplement C3 _xmetabolism |
| 650 | 0 | 4 | _aComplement Fixation Tests |
| 650 | 0 | 4 | _aCytotoxicity Tests, Immunologic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aLymphocyte Culture Test, Mixed |
| 650 | 0 | 4 | _aProtease Inhibitors |
| 650 | 0 | 4 |
_aReceptors, Complement _xphysiology |
| 650 | 0 | 4 | _aReceptors, Complement 3d |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 700 | 1 | _aAlgarra, I | |
| 700 | 1 | _aSármay, G | |
| 700 | 1 | _aYefenof, E | |
| 700 | 1 | _aGergely, J | |
| 700 | 1 | _aKlein, E | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 142 _gno. 1 _gp. 217-23 |
|
| 999 |
_c2527211 _d2527211 |
||